Retrogen utilizes one of the industries top-rated platforms for Next Generation Sequencing (NGS) enabling massively parallel sequencing for almost any molecular genetics application. The flexible and scalable nature of the technology allows investigators to interrogate genomes, exomes, transcriptomes or even just thousands of PCR amplicons in parallel, leading to significant data sets and decreased time to a conclusion. With the ability to multiplex using sample indices, your throughput will reach new speeds.
Retrogen uses Illumina’s sequencing by synthesis chemistry compatible with the MiSeq and enabling small genome de novo or resequencing, SNP profiling, targeted enrichment and amplicon sequencing. With Retrogen’s NGS offering workflows that support clinical diagnostics, prenatal testing and women’s health, all available under CLIA/CAP regulated environment. Contact your sales representatie today to bring your research into the next generation.
Types of Service
De novo sequencing
Cancer Hotspot Panel v2
Childhood Cancer Panel
Comprehensive Cancer Panel
|xGen Lockdown Panels (IDT)
Inherited disease panel
|KAPA Hyper Prep Kits For Library Construction
gDNA, mtDNA and cDNA derived amplicons
Vector/Plasmid Insert sequencing
High Sample Volume Genotyping
Metagenomics (16S rRNA)
Features & Benefits
Data routinely above Q30
Quick Turnaround time
Design / Review / Confirm / Order -> Sample QC -> Library Construction -> Sequencing QC -> Sequencing -> Data Analysis
How To Order
NGS sequencing stands as a beacon of innovation in the field of genetics, offering an efficient and powerful approach to decoding the mysteries of DNA. As technology progresses, the impact of NGS on scientific understanding and medical advancements is poised to grow exponentially. Navigate the future of genetics with NGS sequencing, where each sequenced strand represents a step closer to unlocking the next frontier in genomic exploration.